Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE1
Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A